BSEBoard Meeting13 Aug 2026 · 13 Aug 2026, 05:15 pm
Outcome of the board meeting
Veerhealth Care Ltd · 511523
✦ AI SummaryResults
Veerhealth Care Ltd's board meeting outcome announced on August 13, 2026, approved unaudited financial results for June 30, 2026, and appointed a new company secretary and compliance officer. The board also decided to convene the 34th Annual General Meeting on September 23, 2026, through video conferencing.
Analysis Scores
Earnings Impact6/10
Growth Catalyst2/10
Governance Concern5/10
Regulatory Risk3/10
Balance Sheet Risk8/10
Liquidity Impact7/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Veerhealth Care Ltd - 511523 - Board Meeting Outcome for Outcome Of The Board Meeting
Attachments (1)
📄pdf
Download →
22640bf8-d705-4cd2-a168-f257bba14dea.pdf
View document text
~Veerhealth
Cam Ltd.
CIN : L65910MH1992PLC067632
Date: 13th August, 2026
BSELimited
Department of Corporate Services
P. J. Towers, Dalal Street,
Fort, Mumbai- 400001.
Scrip Code: 511523
Sub: Outcome of Board Meeting
Dear Sir,
Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 ("SEBI LODR") (read with Schedule Ill) including circulars issued thereunder and
other applicable provisions, if any, as amended from time to time, and in continuation to our
intimation dated August 5, 2026 we wish to inform you that the Board of Directors of the Company at
its meeting held today i.e. August 13, 2026 [commenced at 16:00 Hrs (1ST) and concluded at 17:00
Hrs (IST)] has, inter-alia, considered and approved the following matters:
1. Approved Unaudited Financial Results for June 30, 2026 along with the Limited Review
Report. Statement showing Unaudited Financial Results and Limited Review Report for the
Quarter ended June 30, 2026 is enclosed as Annexure-A
2. Approved Director's Report for the financial year ending 31st March, 2026.
3. The Board has decided to convene the 34th Annual General Meeting of the Company on
Wednesday, 23rd September, 2026 at 04.00 P.M. through video conferencing.
4. Resignation of Ms. Asbita Chittora (A50327), as Company Secretary and Compliance
Officer of the Company w.e.f J31 August, 2026.
The Board of Directors of the Company at its meeting held today i.e. on August 13, 2026,
took note of the resignation tendered by Ms. Ashita Chittora as Company Secretary and
Compliance Officer ofVeerhealth Care Ltd with effect from the closure of the business hours
of August 13,2026, due to pursuance of better opportunity.
Further, detailed information as required under Regulation 30 of the SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular
SEBIIHO/CFD/PoD2/CIRIP/01 55 dated November 11. 2024, in respect of aforesaid
resignation and the resignation letter is enclosed as Annexure B.
5. Appointment of Ms. Rucbi Sbab (Membership Number: A80942) as tbe Company
Secretary & Compliance Officer of the Company.
Pursuant to Regulation 30 and other applicable provisions, we wish to inform you that based
on the recommendation of the Nomination and Remuneration Committee. the Board of
Directors in its meeting held on August 13, 2026 has considered and approved the
appointment of Ms. Ruchi Shah as the Company Secretary & Compliance Officer of the
company in pursuance to the provisions of Section 203 of the Companies Act, 2013. read with
Reg. Off.: 629-A Gazdar House, I st Floor, Near Kalbadevi Post Office, J.S.S. Marg. Mumbai-400 002.
Tel. No.: (022) 22018582 Fax No.: (022) 22072644 E-mail: info@veerhealthcare.net Website: www.veerhealthcare.net • www.ayuveer.com
Works: Plot No. 224, Vibrant Business Park, Opp UPL, National Highway No. B, Vapi-39619 I, Gujarat
Rule 8 of Companies {Appointment and Remuneration ofManagerial Personnel) Rules, 2014
and other applicable provisions, if any with effect from August 13, 2026.
Disclosure required pursuant to Regulation 30 ofSEBI LODR read with Clause 7, Para A of
Part A of Schedule Ill to the said Regulation read with the SEBI Master Circular no.
SEBI/HO/CFD/PoD2/CIRIP/0155 dated November I I, 2024, with regards to change in
Directors and Key Managerial Personnel is enclosed as Annexure-C.
Ms. Ruchi Shah is related to the Directors or Key Managerial Personnel or Promoters of the
Company. Her brief profile is annexed with this communication as Annexure -C.
Kindly take the above information on record and oblige.
Thanking You.
Yours faithfully,
For Veerbealtb Care Limited
Bhavin S. Shah
Managing Director
DIN: 03129574
Reg. Off.; 629-A Gazdar House, Is t Floor, Near Kalbadevi Post Office, J.S.S. Marg, Mumbai -400 002.
Tel. No.: (022) 22018582 Fax No.: (022) 22072644 E-mail: info@veerhealthcare.net Website: www.veerhealthcare.net • www.ayuveer.com
Works : Plot No. 224, Vibrant Business Park, Opp UPL, National Highway No. B, Vapi -39619 I, Gujarat
VEER HEALTH CARE LIMITED
Regd Office: 629-A, Gazdar House, 1st Floor, ].S.S. Marg, Near Kalbadevi Post Office, Mumbai -400002.
Tel. No. 022-22018532 CIN: L65910MH1992PLC067632
Email: info@veerhealthcare.net Website: www.veerhealthcare.net
Statement of Unaudited Financial Results for the Quarter ended June 30, 2026
(Amount in lakhs}
Standalone
Sr. No. Particubrs
Quarter ended Quarter ended Quarter ended Year ended
30-06-2026 31-03-2026 30-06-2025 31-03-2026
Unaudited Audited Unaudited Audited
1 Revenue from operations 2492.56 1676.14 448.52 3248.45
u Other Income 16.09 2152 65.04 80.16
m Total Revtnue (I + 11) 2508.65 1697.66 513.56 3328.61
IV Expenses:
(a) Cost of materials consumed 0.00 0.00 0.00
(b) Purchase of stock-in-trade 2551.38 1395.95 304..63 2615.44
(c) Changes in inventories of finished goods,
work-in-progress and stock-in-trade -516.29 16.35 47.96 -200.38
(d) Employee benelrts expense 66ZJ 44.34 44.07 171.40
(e) Finance Costs 23.28 10.79 9.51 40.22
(t) Depreciation and amortisation expense 35.93 34.79 27.85 129.13
(g) Other expenses 20M2 146.42 55.48 416.01
Total Expenses 2360.99 1648.64 48950 3171.82
v ProfiV(Loss) before exceptional items (m -IV) 14.7.66 49.02 24.06 156.79
VI Exceptional items 0.00 31.00 0.00 31.00
VII Profit before tax (V-VI) 147.66 18.02 24.06 125.79
vm Tax expense:
1) Current Tax 25.00 4.00 0.00 22.00
2) Prior Year Tax 0.00 0.00 0.00 0.00
2) Deferred Tax 0.00 49.39 0.00 49.39
IX ProfiV(Loss) for the period (Vll-Vlll) 122.66 -3537 24.06 54.40
X Other Comprehensin Income
(a) Items that will not be reclassified to Profit or Los. 0.00 0.00 0.00 0.00
(b) Income Tax effect on above 0.00 0.00 0.00 0.00
Other Comprehensive Income 0.00 0.00 0.00 0.00
XI Total Comprehe.nsive Income for the period (IX+ X) 122.66 -35.37 24.06 54.40
XII Paid-up equity share capital of Rs. 10 each 1999.85 1999.85 1999.85 1999.85
XIII Other Equity 902.38 292.47 222.03 292.47
XIV Net Worth 2902.23 2292.32 2221.88 2292.32
XV Earnings Pe.r Share (of Rs. 10 each):
(a) Basic (in Rs.) 0.61 -0.18 0.12 0.27
(h) Diluted (in Rs.) 0.57 -0.18 o.u 0.27
VEERHEALT H CARE LIMITED
Regd Office: 629-A, Gazdar Hoose, 1st Floor, J.S.S. Marg,. Near K.albadevi Post Office, Mumbai -400002.
Tel No. 022-22018582 ClN: L65910MH1992PLC067632
Email: info@veerhealthcare.net Website: www.veerhealthcare.net
NOTES:
The above financial results have been revicwro by the Aurut Committee and approvoo by the Board of Directors at their meeting held on 13th Augusl, 2026.
2 1he standalone financial results of lhe Company have been prepared in accordance with lhe ln<lian Accounting Standards ('IND AS') prescribed under Section 133 of lhe
Companies Act, 2013 ("the Act") read with relevant rules issued thereunder and guidelines issu<'<l by the Securities and Exchange Board of India ("SEBr).
During the quarter ended june 30, 2026 lhe Company is operating in a single segment ie. 'Healthcare Pharma Products'. Accordingly, segment wise reporting is not
applicable.
During the quarter, the Company received approval for the issue ofl,OO,OO,OOO warrants, convertible into an equivalent number of equity shares of nO each, on a
prefe.rential basis at an issue price of ~20.25 per warrant, aggregating to ~2.025lakh, pursuant to lhe approval of the shareholders and in accordance with lhe applicable
4 provisions of the SEBIICDR Regulations. Consequent to the issue of the aforesaid warrants, an amount of f487. 25 lakh has been received from the proposed aUottees up
to June 30, 2026, being part consideration towa.rds the said warrants.
5 I regrouped wherever necessary.
6 1he financial results of the Company are ava.ilable at www.bseindia.com and at www. veerhealthcare.net
By order of the Board
For V~rh~alth Care Limit~d
Bhavin S. Shah
Place: Mumbai Managing Director
Date: 13th August, 2026 DIN: 03129574
Jayesh R Shah & Co CA .Jayesh Shah
CA Kruti Doshi
.l.ndJmenden1Au.ditor's Limited Review Report on the Quarterly and Year to Date Unaudit
[Showing first 8,000 characters — download PDF for full document]